The goal of this clinical trial is to find out whether hearing test results using functional near-infrared spectroscopy (fNIRS) will help to fast-track early intervention for infants born with a hearing loss. fNIRS is a method of imaging brain activity using light. The main questions are:
1. Can audiologists make more confident decisions about the optimal interventions at different critical points in the hearing care pathway when they are given additional fNIRS information compared to when they have standard audiology test results alone? 2. Is the experience of their infant having an fNIRS test acceptable and comfortable for the parents or care givers?
Is a qualified audiologist who meets the criteria for membership of Audiology Australia.
Has at least 1 year of experience in paediatric diagnostic, hearing aid or cochlear implant audiology service provision in Australia.
Provides a signed and dated informed consent form.
Is the managing audiologist for the infant who's results are being provided.
Between the ages of 1 and 24 months at the time of fNIRS testing.
Has permanent hearing loss in one or both ears as determined by audiological diagnostic testing.
Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.